Tauns Laboratories, Inc. (JP:197A) has released an update.
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
TAUNS Laboratories, Inc. has signed a Memorandum of Understanding with Roche Diagnostics K.K. to enter into a Master Transaction Agreement for the sale of TAUNS’ products, aiming to enhance business growth for both companies. The agreement will cover specific diagnostic products and is set to commence in January 2025.
For further insights into JP:197A stock, check out TipRanks’ Stock Analysis page.